![Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hyd…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F363518-cyclopropaneacetic-acid-1-1r-1-3-1e-2-7-chloro-2-quinolinyl-ethenyl-phenyl-3-2-1-hydroxy-1-methylethyl-phenyl-propyl-thio-methyl-sodium-salt-1-1.webp&w=3840&q=75)
CAS 151767-02-1
:Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
Description:
Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1) is a complex organic compound characterized by its unique structural features, including a cyclopropane ring and various functional groups that contribute to its chemical reactivity and biological activity. As a sodium salt, it is likely to exhibit increased solubility in water compared to its acid form, which can enhance its bioavailability in pharmaceutical applications. The presence of a quinoline moiety suggests potential pharmacological properties, possibly including antimicrobial or anticancer activities. The compound's thioether linkage may also influence its stability and reactivity. Its intricate structure indicates that it may interact with biological targets in a specific manner, making it of interest in medicinal chemistry. Overall, this compound exemplifies the complexity often found in drug-like molecules, combining multiple functional groups that can impart diverse chemical and biological properties.
Formula:C35H36ClNO3S·Na
InChI:InChI=1S/C35H36ClNO3S.Na/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);/b15-10+;/t32-;/m1./s1
InChI key:InChIKey=ZMFQNQCXWQXCFO-HKHDRNBDSA-N
SMILES:C(S[C@H](CCC1=C(C(C)(C)O)C=CC=C1)C2=CC(/C=C/C3=NC4=C(C=C3)C=CC(Cl)=C4)=CC=C2)C5(CC(O)=O)CC5.[Na]
Synonyms:- 1-[[[(R)-1-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt
- 2-[1-[[1-[3-[2-[(7-Chloro-2-Quinolyl)]Vinyl]Phenyl]-3-[2-(1-Hydroxy-1-Methyl-Ethyl)Phenyl]-Propyl]Sulfanylmethyl]Cyclopropyl]Acetic Acid Sodium Salt
- 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid sodium salt
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt
- Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
- Cyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, monosodium salt, [R-(E)]-
- Kokast
- Methyl-[E]-(+)-1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)-ethenyl]phenyl]-3-[2-(1-hydroxyl-1-methylethyl)phenyl]propyl]mercapto]methyl]cyclopropane acetic acid sodium
- Mk-476
- Momazol
- Montair
- Montelukast Sodium Amorphous
- Montelukast monosodium salt
- Montikast
- Shantroz
- Singulair
- Sodium 2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate
- Sodium montelukast
- sodium (1-{[(1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl)sulfanyl]methyl}cyclopropyl)acetate
- sodium {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetate
- sodium(R,E)-2-(1-(1-(3-(-(7-chloroqulnolln-2-yl)-3-(2-(2 hydroxypropan-2-yl)phenyl)propylthio)cyclopropyl)acetate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 19 products.
MONTELUKAST FOR PEAK IDENTIFICATION CRS
CAS:<p>MONTELUKAST FOR PEAK IDENTIFICATION CRS</p>Formula:C35H35ClNNaO3SMolecular weight:608.1651MONTELUKAST SODIUM CRS
CAS:<p>MONTELUKAST SODIUM CRS</p>Formula:C35H35ClNNaO3SMolecular weight:608.1651Montelukast Sodium
CAS:<p>Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused</p>Formula:C35H35ClNO3S·NaColor and Shape:White Off-White PowderMolecular weight:607.19239Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
CAS:Formula:C35H35ClNNaO3SPurity:98%Color and Shape:SolidMolecular weight:608.1651Montelukast sodium salt
CAS:Formula:C35H35NO3ClNaSPurity:≥ 99.0%Color and Shape:White to almost white powder or crystalsMolecular weight:608.17057Montelukast Sodium Salt
CAS:Formula:C35H35ClNO3S·NaColor and Shape:Pale Yellow SolidMolecular weight:585.18 22.99Montelukast sodium
CAS:Controlled ProductFormula:C35H35ClNO3S·NaColor and Shape:NeatMolecular weight:608.17Montelukast Sodium
CAS:Controlled ProductFormula:C35H35ClNO3S·NaColor and Shape:NeatMolecular weight:608.17Montelukast Sodium
CAS:Formula:C35H35ClNNaO3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:608.17Montelukast sodium
CAS:<p>Montelukast sodium (MK0476), an oral leukotriene antagonist for asthma, can cause rare liver injury.</p>Formula:C35H35ClNNaO3SPurity:99.14% - 99.89%Color and Shape:White To Off-White Crystalline PowderMolecular weight:608.17Montelukast Sodium Salt
CAS:Controlled Product<p>Applications A selective leukotriene D4-receptor antagonist. Used as an antiasthmatic.<br>References Labelle, M., et al.: Bioorg. Med. Chem. Lett., 5, 283 (1995), Jones, T.R., et al.: Can. J. Physiol. Pharmacol., 73, 191 (1995), Markham, A. and Faulds, D.: Drugs, 56, 251 (1998)<br></p>Formula:C35H35ClNO3S·NaColor and Shape:White To Light YellowMolecular weight:608.17Montelukast sodium salt - Bio-X ™
CAS:<p>Montelukast is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.</p>Formula:C35H36ClNO3S•NaPurity:Min. 95%Color and Shape:PowderMolecular weight:608.17 g/molMontelukast sodium
CAS:<p>Montelukast sodium is a leukotriene receptor antagonist that blocks the binding of leukotrienes to their receptors. It is used for the treatment of chronic cough, as well as for the relief of symptoms of seasonal and perennial allergic rhinitis. Montelukast sodium binds to leukotriene receptors on cells in the airways, preventing them from attaching to leukotrienes and triggering an inflammatory response. This drug has been shown to be effective in controlling asthma symptoms by reducing bronchial hyperresponsiveness and relieving respiratory obstruction due to inflammation. Montelukast sodium also has anti-inflammatory properties, which are thought to be due to its ability to inhibit production of pro-inflammatory cytokines such as IL-6.</p>Formula:C35H35ClNNaO3SPurity:Min. 95%Color and Shape:PowderMolecular weight:608.17 g/molMontelukast-d6 Sodium Salt
CAS:Controlled ProductFormula:C35H29D6ClNNaO3SColor and Shape:NeatMolecular weight:614.2
![Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hyd…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA003S60.jpg&w=3840&q=75)
